{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T04:05:21Z","timestamp":1751256321548,"version":"3.41.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T00:00:00Z","timestamp":1751155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T00:00:00Z","timestamp":1751155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12029-025-01264-2","type":"journal-article","created":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T02:51:42Z","timestamp":1751165502000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of Patients with Early-Stage Hepatocellular Carcinoma Benefiting from Neoadjuvant Chemotherapy\u2014A SEER-Based Study"],"prefix":"10.1007","volume":"56","author":[{"given":"Shigang","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linhao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,29]]},"reference":[{"key":"1264_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16:589\u2013604. https:\/\/doi.org\/10.1038\/s41575-019-0186-y.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1264_CR2","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMra1001683","volume":"365","author":"HB El-Serag","year":"2011","unstructured":"El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365:1118\u201327. https:\/\/doi.org\/10.1056\/NEJMra1001683.","journal-title":"N Engl J Med"},{"key":"1264_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/hep.27388","volume":"61","author":"B Njei","year":"2015","unstructured":"Njei B, Rotman Y, Ditah I, Lim JK. Emerging trends in hepatocellular carcinoma incidence and mortality. Hepatol Baltim Md. 2015;61:191\u20139. https:\/\/doi.org\/10.1002\/hep.27388.","journal-title":"Hepatol Baltim Md"},{"key":"1264_CR4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s10552-020-01386-x","volume":"32","author":"X Zhang","year":"2021","unstructured":"Zhang X, El-Serag HB, Thrift AP. Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare. Cancer Causes Control CCC. 2021;32:317\u201325. https:\/\/doi.org\/10.1007\/s10552-020-01386-x.","journal-title":"Cancer Causes Control CCC"},{"key":"1264_CR5","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1016\/j.cgh.2015.08.014","volume":"13","author":"AG Singal","year":"2015","unstructured":"Singal AG, El-Serag HB. Hepatocellular carcinoma from epidemiology to prevention: translating knowledge into practice. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2015;13:2140\u201351. https:\/\/doi.org\/10.1016\/j.cgh.2015.08.014.","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"1264_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acr.2020.10.001","volume":"149","author":"S Chidambaranathan-Reghupaty","year":"2021","unstructured":"Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D. Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification. Adv Cancer Res. 2021;149:1\u201361. https:\/\/doi.org\/10.1016\/bs.acr.2020.10.001.","journal-title":"Adv Cancer Res"},{"key":"1264_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1136\/archdischild-2015-310023","volume":"103","author":"R Kohli","year":"2018","unstructured":"Kohli R, Cortes M, Heaton ND, Dhawan A. Liver transplantation in children: state of the art and future perspectives. Arch Dis Child. 2018;103:192\u20138. https:\/\/doi.org\/10.1136\/archdischild-2015-310023.","journal-title":"Arch Dis Child"},{"key":"1264_CR8","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.3748\/wjg.v25.i28.3704","volume":"25","author":"C Akateh","year":"2019","unstructured":"Akateh C, Black SM, Conteh L, Miller ED, Noonan A, Elliott E, et al. Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma. World J Gastroenterol. 2019;25:3704\u201321. https:\/\/doi.org\/10.3748\/wjg.v25.i28.3704.","journal-title":"World J Gastroenterol"},{"key":"1264_CR9","doi-asserted-by":"publisher","first-page":"8069","DOI":"10.3748\/wjg.v27.i47.8069","volume":"27","author":"H-T Zhao","year":"2021","unstructured":"Zhao H-T, Cai J-Q. Chinese expert consensus on neoadjuvant and conversion therapies for hepatocellular carcinoma. World J Gastroenterol. 2021;27:8069\u201380. https:\/\/doi.org\/10.3748\/wjg.v27.i47.8069.","journal-title":"World J Gastroenterol"},{"key":"1264_CR10","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/S1470-2045(15)00198-9","volume":"16","author":"J Bruix","year":"2015","unstructured":"Bruix J, Takayama T, Mazzaferro V, Chau G-Y, Yang J, Kudo M, et al. Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2015;16:1344\u201354. https:\/\/doi.org\/10.1016\/S1470-2045(15)00198-9.","journal-title":"Lancet Oncol"},{"issue":"4","key":"1264_CR11","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41571-024-00868-0","volume":"21","author":"JM Llovet","year":"2024","unstructured":"Llovet JM, Pinyol R, Yarchoan M, Singal AG, Marron TU, Schwartz M, Pikarsky E, Kudo M, Finn RS. Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma. Nat Rev Clin Oncol. 2024;21(4):294\u2013311. https:\/\/doi.org\/10.1038\/s41571-024-00868-0.","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"1264_CR12","doi-asserted-by":"publisher","first-page":"e0430","DOI":"10.1097\/HC9.0000000000000430","volume":"8","author":"AG Singal","year":"2024","unstructured":"Singal AG, Yarchoan M, Yopp A, Sapisochin G, Pinato DJ, Pillai A. Neoadjuvant and adjuvant systemic therapy in HCC: current status and the future. Hepatol Commun. 2024;8(6):e0430. https:\/\/doi.org\/10.1097\/HC9.0000000000000430.","journal-title":"Hepatol Commun"},{"key":"1264_CR13","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/cam4.3613","volume":"10","author":"B Yan","year":"2021","unstructured":"Yan B, Su B-B, Bai D-S, Qian J-J, Zhang C, Jin S-J, et al. A practical nomogram and risk stratification system predicting the cancer-specific survival for patients with early hepatocellular carcinoma. Cancer Med. 2021;10:496\u2013506. https:\/\/doi.org\/10.1002\/cam4.3613.","journal-title":"Cancer Med"},{"key":"1264_CR14","doi-asserted-by":"publisher","first-page":"848716","DOI":"10.3389\/fpubh.2022.848716","volume":"10","author":"C Wen","year":"2022","unstructured":"Wen C, Tang J, Luo H. Development and validation of a nomogram to predict cancer-specific survival for middle-aged patients with early-stage hepatocellular carcinoma. Front Public Health. 2022;10:848716. https:\/\/doi.org\/10.3389\/fpubh.2022.848716.","journal-title":"Front Public Health"},{"key":"1264_CR15","doi-asserted-by":"publisher","first-page":"789026","DOI":"10.3389\/fpubh.2021.789026","volume":"9","author":"T He","year":"2021","unstructured":"He T, Chen T, Liu X, Zhang B, Yue S, Cao J, et al. A web-based prediction model for cancer-specific survival of elderly patients with early hepatocellular carcinoma: a study based on SEER database. Front Public Health. 2021;9:789026. https:\/\/doi.org\/10.3389\/fpubh.2021.789026.","journal-title":"Front Public Health"},{"key":"1264_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ygyno.2022.11.023","volume":"169","author":"J Du","year":"2023","unstructured":"Du J, Cheng Y, Hu D, Xing Y, Yue L, He R, et al. A nomogram-based overall survival stratification to identify uterine sarcoma patients without distant metastases who may benefit from adjuvant radiotherapy. Gynecol Oncol. 2023;169:17\u201326. https:\/\/doi.org\/10.1016\/j.ygyno.2022.11.023.","journal-title":"Gynecol Oncol"},{"key":"1264_CR17","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.annonc.2020.04.003","volume":"31","author":"D Dong","year":"2020","unstructured":"Dong D, Fang M-J, Tang L, Shan X-H, Gao J-B, Giganti F, et al. Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: an international multicenter study. Ann Oncol Off J Eur Soc Med Oncol. 2020;31:912\u201320. https:\/\/doi.org\/10.1016\/j.annonc.2020.04.003.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"1264_CR18","doi-asserted-by":"publisher","first-page":"e214","DOI":"10.1097\/SLA.0000000000003450","volume":"273","author":"TR Semenkovich","year":"2021","unstructured":"Semenkovich TR, Yan Y, Subramanian M, Meyers BF, Kozower BD, Nava R, et al. A clinical nomogram for predicting node-positive disease in esophageal cancer. Ann Surg. 2021;273:e214\u201321. https:\/\/doi.org\/10.1097\/SLA.0000000000003450.","journal-title":"Ann Surg"},{"key":"1264_CR19","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/neuonc\/noz191","volume":"22","author":"H Gittleman","year":"2020","unstructured":"Gittleman H, Sloan AE, Barnholtz-Sloan JS. An independently validated survival nomogram for lower-grade glioma. Neuro-Oncol. 2020;22:665\u201374. https:\/\/doi.org\/10.1093\/neuonc\/noz191.","journal-title":"Neuro-Oncol"},{"key":"1264_CR20","doi-asserted-by":"publisher","unstructured":"(2018) Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Lancet Oncol 19:27\u201339. https:\/\/doi.org\/10.1016\/S1470-2045(17)30777-5","DOI":"10.1016\/S1470-2045(17)30777-5"},{"key":"1264_CR21","doi-asserted-by":"publisher","first-page":"987603","DOI":"10.3389\/fonc.2022.987603","volume":"12","author":"D Yang","year":"2022","unstructured":"Yang D, Zhu M, Xiong X, Su Y, Zhao F, Hu Y, et al. Clinical features and prognostic factors in patients with microvascular infiltration of hepatocellular carcinoma: development and validation of a nomogram and risk stratification based on the SEER database. Front Oncol. 2022;12:987603. https:\/\/doi.org\/10.3389\/fonc.2022.987603.","journal-title":"Front Oncol"},{"key":"1264_CR22","doi-asserted-by":"publisher","first-page":"23754","DOI":"10.1038\/s41598-021-02698-x","volume":"11","author":"M Liu","year":"2021","unstructured":"Liu M, Xu M, Tang T. Association between chemotherapy and prognostic factors of survival in hepatocellular carcinoma: a SEER population-based cohort study. Sci Rep. 2021;11:23754. https:\/\/doi.org\/10.1038\/s41598-021-02698-x.","journal-title":"Sci Rep"},{"issue":"69","key":"1264_CR23","doi-asserted-by":"publisher","first-page":"102782","DOI":"10.1016\/j.amsu.2021.102782","volume":"2021","author":"K Qayum","year":"2012","unstructured":"Qayum K, Kar I, Rashid U, Nawaz G, Krishnakumar P, Sudarshan V, et al. Effects of surgery, chemotherapy, and radiation on hepatocellular carcinoma patients: a SEER-based study. Ann Med Surg. 2012;2021(69):102782. https:\/\/doi.org\/10.1016\/j.amsu.2021.102782.","journal-title":"Ann Med Surg"},{"key":"1264_CR24","doi-asserted-by":"publisher","first-page":"652768","DOI":"10.3389\/fonc.2021.652768","volume":"11","author":"H Zhan","year":"2021","unstructured":"Zhan H, Zhao X, Lu Z, Yao Y, Zhang X. Correlation and survival analysis of distant metastasis site and prognosis in patients with hepatocellular carcinoma. Front Oncol. 2021;11:652768. https:\/\/doi.org\/10.3389\/fonc.2021.652768.","journal-title":"Front Oncol"},{"key":"1264_CR25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.21873\/invivo.12270","volume":"35","author":"D Giannis","year":"2021","unstructured":"Giannis D, Morsy S, Geropoulos G, Esagian SM, Sioutas GS, Moris D. The epidemiology, staging and outcomes of sarcomatoid hepatocellular carcinoma: a SEER population analysis. Vivo Athens Greece. 2021;35:393\u20139. https:\/\/doi.org\/10.21873\/invivo.12270.","journal-title":"Vivo Athens Greece"},{"key":"1264_CR26","doi-asserted-by":"publisher","first-page":"653437","DOI":"10.3389\/fimmu.2021.653437","volume":"12","author":"Z-Y Qiao","year":"2021","unstructured":"Qiao Z-Y, Zhang Z-J, Lv Z-C, Tong H, Xi Z-F, Wu H-X, et al. Neoadjuvant programmed cell death 1 (PD-1) inhibitor treatment in patients with hepatocellular carcinoma before liver transplant: a cohort study and literature review. Front Immunol. 2021;12:653437. https:\/\/doi.org\/10.3389\/fimmu.2021.653437.","journal-title":"Front Immunol"},{"key":"1264_CR27","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ejso.2012.01.006","volume":"38","author":"J-H Zhong","year":"2012","unstructured":"Zhong J-H, Li H, Li L-Q, You X-M, Zhang Y, Zhao Y-N, et al. Adjuvant therapy options following curative treatment of hepatocellular carcinoma: a systematic review of randomized trials. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2012;38:286\u201395. https:\/\/doi.org\/10.1016\/j.ejso.2012.01.006.","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"key":"1264_CR28","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc J-F, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378\u201390. https:\/\/doi.org\/10.1056\/NEJMoa0708857.","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"1264_CR29","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.1007\/BF00647249","volume":"23","author":"M Monden","year":"1989","unstructured":"Monden M, Okamura J, Sakon M, Gotoh M, Kobayashi K, Umeshita K, et al. Significance of transcatheter chemoembolization combined with surgical resection for hepatocellular carcinomas. Cancer Chemother Pharmacol. 1989;23(Suppl):S90-95. https:\/\/doi.org\/10.1007\/BF00647249.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1264_CR30","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1002\/1097-0142(20001215)89:12<2606::AID-CNCR13>3.0.CO;2-T","volume":"89","author":"Z Zhang","year":"2000","unstructured":"Zhang Z, Liu Q, He J, Yang J, Yang G, Wu M. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma. Cancer. 2000;89:2606\u201312.","journal-title":"Cancer"},{"key":"1264_CR31","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S1665-2681(19)30846-4","volume":"13","author":"L Jianyong","year":"2014","unstructured":"Jianyong L, Jinjing Z, Wentao W, Lunan Y, Qiao Z, Bo L, et al. Preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: a single center analysis. Ann Hepatol. 2014;13:394\u2013402.","journal-title":"Ann Hepatol"},{"key":"1264_CR32","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2147\/JHC.S300182","volume":"8","author":"A Koulouris","year":"2021","unstructured":"Koulouris A, Tsagkaris C, Spyrou V, Pappa E, Troullinou A, Nikolaou M. Hepatocellular carcinoma: an overview of the changing landscape of treatment options. J Hepatocell Carcinoma. 2021;8:387\u2013401. https:\/\/doi.org\/10.2147\/JHC.S300182.","journal-title":"J Hepatocell Carcinoma"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01264-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-025-01264-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01264-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T15:02:26Z","timestamp":1751209346000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-025-01264-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,29]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1264"],"URL":"https:\/\/doi.org\/10.1007\/s12029-025-01264-2","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"type":"print","value":"1941-6628"},{"type":"electronic","value":"1941-6636"}],"subject":[],"published":{"date-parts":[[2025,6,29]]},"assertion":[{"value":"19 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethical approval is required for the use of anonymous, publicly available data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Permission has been obtained from all authors to publish this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"144"}}